What is the efficacy of Arctostaphylos uva-ursi (UVA ursi)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Efficacy of Arctostaphylos uva-ursi (UVA ursi)

  • The efficacy of Arctostaphylos uva-ursi (UVA ursi) in treating urinary tract infections (UTIs) has been investigated in several studies 1, 2, 3.
  • A double-blind, randomized, controlled comparative effectiveness trial found that initial treatment with UVA ursi reduced antibiotic use by 63.6% compared to fosfomycin, but led to a higher symptom burden and more safety concerns 2.
  • Another study found that UVA ursi extract and ibuprofen may be alternative treatments for adult female UTI, but further research is needed to confirm their effectiveness 3.
  • A review of non-steroidal anti-inflammatory drugs (NSAIDs) for treating symptomatic uncomplicated UTIs found that NSAIDs probably result in less short-term resolution of symptoms and greater use of rescue antibiotics by day 30 compared to primary antibiotic treatment, but may make little or no difference to adverse events 4.
  • The use of UVA ursi as a treatment for UTIs may be associated with a higher risk of complications, such as pyelonephritis, compared to antibiotic treatment 2.

Comparison to Other Treatments

  • UVA ursi has been compared to fosfomycin, an antibiotic, in the treatment of UTIs, and was found to reduce antibiotic use but increase symptom burden 2.
  • UVA ursi has also been compared to ibuprofen, an NSAID, and was found to have similar efficacy in reducing symptom severity 3.
  • The use of UVA ursi as a treatment for UTIs may be considered as an alternative to antibiotic treatment, but further research is needed to confirm its effectiveness and safety 1, 2, 3.

Safety and Adverse Events

  • The safety and adverse event profile of UVA ursi has been investigated in several studies, and was found to be similar to that of fosfomycin and ibuprofen 2, 3.
  • However, the use of UVA ursi may be associated with a higher risk of complications, such as pyelonephritis, compared to antibiotic treatment 2.
  • Further research is needed to fully understand the safety and adverse event profile of UVA ursi as a treatment for UTIs 1, 2, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.